Registered entities
Phasebio Pharmaceuticals Inc
Reg. No. 1169245United States
Phasebio Pharmaceuticals, Inc.
Reg. No. 30375697United States
Innovation
24 patent families (11 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,517 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2013 | 6 |
| 2014 | 7 |
| 2015 | 9 |
| 2016 | 5 |
| 2017 | 8 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 8 |
| 2021 | 11 |
| 2022 | 9 |
| 2023 | 3 |
Investor mix
14 investors on record; lead investors include New Enterprise Associates, AstraZeneca, Fletcher Spaght, Johnson & Johnson Innovation; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 50% |
| Other / undisclosed | 7 | 50% |